Ftse Mib
34.395,62
0,06%
DAX
18.518,03
-0,44%
S&P 500
5.653,37
0,39%
NASDAQ
18.416,11
-0,31%
Bitcoin
64.763,08
-0,14%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Evgen Pharma Plc (EVG) Evgen Pharma Plc (EVG) Notizie

EVG

Evgen Pharma (EVG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
DataOraFonteTitoloSimboloCompagnia
18/03/201908:01UK RegulatoryEvgen Pharma PLC Update on SFX-01 trial read-out datesLSE:EVGEvgen Pharma Plc
05/03/201912:35Alliance NewsAlliance NewsStudy Of Evgen Pharma's SFX-01 Multiple Sclerosis Drug Shows PromiseLSE:EVGEvgen Pharma Plc
05/03/201908:00UK RegulatoryEvgen Pharma PLC SFX-01 data published in peer reviewed journalLSE:EVGEvgen Pharma Plc
06/02/201916:30UK RegulatoryEvgen Pharma PLC Holding(s) in CompanyLSE:EVGEvgen Pharma Plc
05/02/201910:18Alliance NewsAlliance NewsEvgen Pharma Finishes Patient Recruitment For Stroke Treatment TrialLSE:EVGEvgen Pharma Plc
05/02/201908:00UK RegulatoryEvgen Pharma PLC Clinical trial update confirms read-outs on trackLSE:EVGEvgen Pharma Plc
30/01/201918:28UK RegulatoryEvgen Pharma PLC Grant of OptionsLSE:EVGEvgen Pharma Plc
23/01/201908:00RNS Non-RegulatoryEvgen Pharma PLC SFX-01 featured in Nature Reviews Drug DiscoveryLSE:EVGEvgen Pharma Plc
22/01/201908:00UK RegulatoryEvgen Pharma PLC Change of AdviserLSE:EVGEvgen Pharma Plc
19/12/201819:02UK RegulatoryEvgen Pharma PLC Share option exercise and issue of equityLSE:EVGEvgen Pharma Plc
12/12/201812:11Alliance NewsAlliance NewsEvgen Pharma Interim Loss Widens As It Progresses New Drug TrialsLSE:EVGEvgen Pharma Plc
12/12/201808:00UK RegulatoryEvgen Pharma PLC Interim ResultsLSE:EVGEvgen Pharma Plc
10/12/201816:20Alliance NewsAlliance NewsEvgen Pharma Confident It Will Appoint New Adviser As Northland LeavesLSE:EVGEvgen Pharma Plc
10/12/201816:00UK RegulatoryEvgen Pharma PLC Nominated Adviser StatusLSE:EVGEvgen Pharma Plc
04/12/201808:00UK RegulatoryEvgen Pharma PLC Poster Presentation of SFX-01 and Trial UpdateLSE:EVGEvgen Pharma Plc
03/12/201808:01UK RegulatoryEvgen Pharma PLC Notification of Half Year ResultsLSE:EVGEvgen Pharma Plc
19/11/201808:00RNS Non-RegulatoryEvgen Pharma PLC Investor Presentation in ManchesterLSE:EVGEvgen Pharma Plc
08/11/201815:30Alliance NewsAlliance NewsEvgen Pharma Appoints Non-Executive With Investment Banking BackgroundLSE:EVGEvgen Pharma Plc
08/11/201808:01UK RegulatoryEvgen Pharma PLC Directorate ChangesLSE:EVGEvgen Pharma Plc
23/10/201813:55Alliance NewsAlliance NewsDavid And Monique Newlands Build 5% Stake In Evgen Pharma (ALLISS)LSE:EVGEvgen Pharma Plc
18/10/201811:26Alliance NewsAlliance NewsEvgen Pharma Raises GBP750,000 Via Share Placing (ALLISS)LSE:EVGEvgen Pharma Plc
18/10/201808:01UK RegulatoryEvgen Pharma PLC PlacingLSE:EVGEvgen Pharma Plc
18/09/201808:00UK RegulatoryEvgen Pharma PLC Investor SymposiumLSE:EVGEvgen Pharma Plc
11/09/201808:01UK RegulatoryEvgen Pharma PLC Notice of Investor SymposiumLSE:EVGEvgen Pharma Plc
26/07/201816:22UK RegulatoryEvgen Pharma PLC Result of AGMLSE:EVGEvgen Pharma Plc
26/07/201813:54Alliance NewsAlliance NewsEvgen Pharma Expects Final Results From Clinical Trials At End Of YearLSE:EVGEvgen Pharma Plc
26/07/201808:02UK RegulatoryEvgen Pharma PLC AGM StatementLSE:EVGEvgen Pharma Plc
25/07/201814:31Alliance NewsAlliance NewsEvgen Pharma Metastatic Breast Cancer Trial Ends Patient RecruitmentLSE:EVGEvgen Pharma Plc
25/07/201808:00UK RegulatoryEvgen Pharma PLC Final Patient Recruited in STEM Phase IIa TrialLSE:EVGEvgen Pharma Plc
10/07/201812:00UK RegulatoryEvgen Pharma PLC Grant of share options, issue of equity and TVRLSE:EVGEvgen Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG

La tua Cronologia

KOSDAQ
340360
Davolink
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network